N. Sympathetic nerve activity and peripheral vasodilator capacity in young and older men. Am J Physiol Heart Circ Physiol 306: H904 -H909, 2014. First published January 10, 2014; doi:10.1152/ajpheart.00181.2013.-Interindividual variability in sympathetic nerve activity (SNA) has provided insight into integrative mechanisms contributing to blood pressure (BP) regulation in humans. In young people, the influence of high SNA on BP is balanced by lower cardiac output and less adrenergic vasoconstrictor responsiveness. Older people have higher SNA and higher BP. We hypothesized that SNA has a restraining effect on peripheral vasodilator responsiveness in young and older men, such that individuals with higher tonic SNA would show less forearm vasodilatation to exogenous vasodilators. We measured muscle SNA (MSNA; microneurography) and forearm vasodilator responses to intra-arterial infusions of acetylcholine (ACh; endothelium dependent) and sodium nitroprusside (SNP; endothelium independent) in 13 young (age; 27 Ϯ 1 yr) and 16 older (61 Ϯ 2 yr) men. Forearm vascular conductance (FVC) responses to ACh were lower in the older men at the two highest doses (2 and 4 g·100 ml Ϫ1 ·min Ϫ1 ; ⌬395 Ϯ 81 vs. 592 Ϯ 87% and 412 Ϯ 87 vs. 616 Ϯ 132%, P Ͻ 0.05), and MSNA was higher (64 Ϯ 4 vs. 41 Ϯ 2 bursts/100 hb; P Ͻ 0.05). There was no difference in the FVC response to SNP between young and older men (P Ͼ 0.05). In young men, there was an inverse relationship between resting MSNA and FVC responses (%change) to both ACh and SNP (r ϭ Ϫ0.83 and r ϭ Ϫ0.83, respectively; P Ͻ 0.05). In older men, however, this relationship was not observed. Tonic SNA may act to restrain vasodilator responses in young men, whereas in older men a lack of such restraint may be protective against the pressor effects of higher SNA. aging; sympathetic; vasodilation SYMPATHETIC NERVE ACTIVITY (SNA) directed toward the peripheral vasculature increases with advancing age in humans (14, 22) . Since SNA is a major contributor to peripheral vasoconstriction and systemic vascular resistance (2, 13), the agerelated increase in SNA is thought to contribute to the increasing risk of developing hypertension as people become older. Complicating the analysis of this issue is the fact that in both young and older healthy humans, resting levels of SNA exhibit striking interindividual variability (2, 18, 24) . People who are otherwise similar (and healthy) can have SNA values that vary by as much as 7-10-fold (2, 18, 22, 24) . Furthermore, in young individuals (up to approximately the age of 40 yr), this range in SNA is not directly related to resting arterial pressure (2, 18). For example, a person with very low SNA might have a resting arterial pressure that is similar to an individual with SNA values several times higher. Importantly, in this context, SNA is very reproducible in a given individual (9).
SYMPATHETIC NERVE ACTIVITY (SNA) directed toward the peripheral vasculature increases with advancing age in humans (14, 22) . Since SNA is a major contributor to peripheral vasoconstriction and systemic vascular resistance (2, 13) , the agerelated increase in SNA is thought to contribute to the increasing risk of developing hypertension as people become older. Complicating the analysis of this issue is the fact that in both young and older healthy humans, resting levels of SNA exhibit striking interindividual variability (2, 18, 24) . People who are otherwise similar (and healthy) can have SNA values that vary by as much as 7-10-fold (2, 18, 22, 24) . Furthermore, in young individuals (up to approximately the age of 40 yr), this range in SNA is not directly related to resting arterial pressure (2, 18) . For example, a person with very low SNA might have a resting arterial pressure that is similar to an individual with SNA values several times higher. Importantly, in this context, SNA is very reproducible in a given individual (9) .
The explanation for these seemingly paradoxical findings appears to lie in a complex interplay among several factors that contribute to arterial blood pressure, each of which exhibits its own level of variability among people. For example, in young men, there is a balance between muscle SNA (MSNA) and cardiac output that acts to offset the effect which each of these variables has on blood pressure (2, 10, 11) . Consequently, young men with high MSNA have lower cardiac output and vice versa (2, 11) . Given that SNA (via vascular resistance) and cardiac output are the two main contributors to arterial pressure, the balance between these factors is an important factor in the maintenance of normal blood pressures in young men with higher MSNA.
After age 40 yr, resting levels of MSNA are related to blood pressure (18) , suggesting that MSNA has a more direct influence on resting blood pressure as humans age. In addition, there is a decrease in endothelium-dependent vasodilator capacity in older men compared with young men (19, 25) . Therefore, it is possible that the elevated levels of resting MSNA observed in older men could be restraining vasodilator capacity in this population, providing an additional mechanism by which higher SNA could contribute to increased risk for hypertension with aging. A caveat to this interpretation is that ␣-adrenergic receptor responsiveness is decreased with age (6), which may be a consequence of the higher SNA due to agonist-mediated downregulation. However, the extent of decreased receptor responsiveness does not appear to be sufficient to offset the influence of SNA on blood pressure, since ganglionic blockade studies demonstrated increased autonomic support of blood pressure in older men (15) .
To gain further insight into these issues, the main goal of the present study was to examine whether there is a relationship between MSNA and vasodilator capacity in a group of healthy older men. We hypothesized that there would be an inverse relationship between forearm vasodilator responses to both acetylcholine (ACh, endothelium dependent) and sodium nitroprusside (SNP, endothelium independent) and MSNA in older men. Such a relationship would suggest that higher MSNA values have the capacity to restrain vasodilator responses.
In a previous study, Charkoudian et al. (3) . did not find a relationship between MSNA and forearm vasodilatation in a group of young people. However, that analysis included both men and women. We have recently shown that differences between men and women in sympathetic ␤-adrenergic receptor vasodilatation result in very different forearm blood flow (FBF) and blood pressure responses to a given level of MSNA (10 -12) . Therefore, a secondary goal of the present study was to reevaluate the potential relationship between MSNA and forearm vasodilation in a group of young healthy men. We hypothesized that both young and older groups would exhibit an inverse relationship between MSNA and forearm vasodilation but that the relationship would be shifted to the right in older men due to overall higher MSNA values in this group.
METHODS
Participants. After the protocol was approved by the Institutional Review Board of the Mayo Clinic, 13 young men (age, 27 Ϯ 1 yr; height, 179 Ϯ 2 cm; weight, 80 Ϯ 3 kg; and body mass index, 24.8 Ϯ 0.7 kg/m 2 ) and 16 older men (age, 61 Ϯ 2 yr; height, 176 Ϯ 1 cm; weight, 82 Ϯ 2 kg; and body mass index, 25.8 Ϯ 0.7 kg/m 2 ) gave written informed consent to participate in this study. The subjects were nonsmokers with no history of cardiovascular or other chronic diseases. Participants were excluded if their body mass index was Ն 30 kg/m 2 or if they were taking any medications. Subjects were asked not to consume anything within 2 h before the experiment, and not to consume caffeine or alcohol for 24 h before the experiment. The cohort of older were deemed healthy and free of cardiovascular disease after they had passed a graded 12-lead ECG submaximal exercise test and standard observations of vital signs were completed (blood pressure, heart rate, tympanic temperature). Men with systolic blood pressure (SBP) Ͼ 140 mmHg measured using a standard sphygmomanometer were not included in this study.
Procedures. All of the studies were performed in a Center for Translational Science Activities Clinical Research Unit laboratory at the Mayo Clinic, where ambient temperature was controlled between 22 and 24°C. On arrival to the laboratory, subjects rested in the supine position during instrumentation. After local anesthesia with 2% lidocaine, a 5-cm, 20-gauge arterial catheter was placed in the brachial artery of the nondominant arm, using aseptic technique. The catheter was connected to a pressure transducer, which was positioned at the level of the heart and interfaced with a personal computer to monitor arterial pressure. A three-lead ECG was used for continuous recordings of heart rate.
Multiunit MSNA was measured from the right peroneal nerve at the fibular head using insulated tungsten microelectrodes. A muscle sympathetic fascicle was identified when taps on the muscle belly or passive muscle stretch evoked mechanoreceptive impulses, and no afferent neural response was evoked by skin stimuli (23, 24) The recorded signal was amplified 80,000-fold, band-pass filtered (700 to 2,000 Hz), rectified, and integrated (resistancecapacitance integrator circuit time constant 0.1 s) by a nerve traffic analyzer.
Stroke volume was measured from the brachial artery using Modelflow analysis. Briefly, the brachial pressure wave was downloaded onto a personal computer and analyzed off-line using data acquisition software (WinDaq194; DATAQ instruments). Beat-tobeat stroke volume was then calculated using Modelflow, which computes an aortic waveform based on nonlinear pressure-volume, pressure-compliance, and pressure-characteristic impedance equations, incorporating age, sex, height, and body mass (26) . Cardiac output was calculated as stroke volume ϫ heart rate, and total peripheral resistance was calculated as mean arterial pressure (MAP)/cardiac output.
FBF was measured using mercury-in-silastic strain gauge plethysmography (16) . Briefly, a pediatric blood pressure cuff was placed around the wrist and inflated to suprasystolic levels (220 mmHg) to arrest the circulation of the hand, and a venous occlusion cuff was placed on the upper arm and rapidly inflated to 50 mmHg every 7.5 s, yielding one blood flow every 15.0 s. FBF was expressed as milliliters per 100 milliliters of tissue per minute.
Brachial artery infusion of ACh and SNP. Infusions of both vasoactive drugs were adjusted for forearm volume and administered via the brachial artery catheter at total rates of 2 to 4 ml/min. ACh (Bedford) was administered at 2, 4, and 8 g·100 ml Ϫ1 ·min Ϫ1 . SNP was administered at 0.5, 1, and 2 mg·100 ml Ϫ1 ·min Ϫ1 . Protocol. After the placement of arterial catheters, ECG leads, and instrumentation for plethysmography, subjects rested supine during instrumentation for microneurography. Once an acceptable electrode site for measurement of MSNA was found, 5 min of baseline data (cardiac output, arterial pressures, ECG, and MSNA) were recorded with the subject resting quietly. After this baseline period, forearm dose-response trials were performed for ACh and SNP at the doses noted above. Each dose-response trial included 2 to 4 min of resting FBF measurement (with saline infused at the same rate as the vasoactive drugs), followed by 2-min infusions of each dose.
Data analysis. Data were sampled at 250 Hz and stored on a personal computer for off-line analysis. MSNA, heart rate, MAP, SBP, and diastolic blood pressure were assessed as 5-min averages at the end of the initial baseline period. Baseline values for FBF were assessed as the averages of the last 2 min of the baseline period. Sympathetic bursts in the integrated neurogram were identified by a custom-manufactured, semiautomated analysis program (2, 17); burst identification was controlled visually by a single investigator. The program then compensated for baroreflex latency and associated each sympathetic burst with the appropriate cardiac cycle. MSNA was expressed as burst incidence (bursts/100 heartbeats). Correlations among variables were similar when MSNA was expressed as bursts per minute. Please see Table 3 for these data.
FBF was determined from the slope of the plethysmographic recording during venous occlusion (16) . FBF data are presented as an average of four measurements during the last minute of each dose of drug infusion, when steady-state vasodilation was observed. Vasodilator responses were analyzed both as absolute change and as the percentages of change in FBF and forearm vascular conductance (FVC) from baseline. FVC was calculated as FBF/MAP ϫ 100.
Statistics. Data were analyzed statistically using commercially available software (Sigma Stat 2.03, SPSS, Chicago, IL). Group data are expressed as means Ϯ SE. Student's t-tests were used to examine whether resting neural and cardiovascular variables were different between each group. A two-way ANOVA was used to measure differences in FBF and FVC response to ACh and SNP in young and older men, with a Bonferroni adjustment for pairwise Values are means Ϯ SE. SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; MSNA, muscle sympathetic nerve activity; FBF, forearm blood flow; FVC, forearm vascular conductance; FAV, forearm volume. *P Ͻ 0.05.
comparisons. To measure whether there was a relationship of baseline MSNA to cardiovascular variables, linear regression analysis was performed and Pearson's correlation coefficients calculated. The ␣-level was set at 0.05.
RESULTS
Resting group neural-hemodynamic variables. Older men had a higher SBP compared with the young men; however, diastolic blood pressure and MAP were similar between the groups (Table 1) . Intra-arterial SBPs were greater than 140 mmHg in some individuals (1 young man and 3 older men). However, intra-arterial pressures are typically higher than blood pressures measured with a standard aneroid sphygmomanometer. Furthermore, none of the men included in this study had SBP Ͼ 140 mmHg, measured using a standard sphygmomanometer. There was no difference in resting stroke volume, cardiac output, or total peripheral resistance between young and older men. Despite this, resting MSNA, when expressed as bursts per min and bursts per 100 heartbeats, was greater in older men compared with young men. There was no difference in resting FVC and FBF between young and older men.
Vasodilator responses to SNP and ACh. FVC responses to ACh were blunted in older men to the two higher doses of ACh (4 and 8 g·100 ml Ϫ1 ·min
Ϫ1
), whether expressed as absolute change [older men, 8.5 Ϯ 1.7 and 10.1 Ϯ 1.7 ml (100 ml forearm volume) min/mmHg vs. young men, 11.5 Ϯ 2.2 and 12.2 Ϯ 2.1 ml (100 ml forearm volume) min/mmHg; P Ͻ 0.05; for each dose respectively] or %change in FVC (Fig. 1) . Conversely, FVC responses to SNP were similar between groups, when expressed as both change and %change in FVC (Fig. 1, bottom) .
Relationship between MSNA and forearm vascular responses to ACh and SNP. In young men basal MSNA (bursts/ 100 heartbeats) was inversely related to the change in FBF in response to all doses of ACh and SNP (Table 2) . Relationships were similar when MSNA was expressed as bursts per min (Table 3) . Additionally, the relationships persisted when both absolute and %changes in FVC in response to ACh and SNP were correlated to basal MSNA (Table 2 and Figs. 2 and 3) . The reader will note that when %changes in FVC are used there is an obvious outlier in the group of young men. When the data from this individual are removed, significant relationships between MSNA and changes in FVC in response to both vasoactive drugs remain (for example at the middle dose of both drugs; ACh, 4 g·100 ml Ϫ1 ·min Ϫ1 ; r ϭ 0.53, P Ͻ 0.05 and SNP, 1 mg·100 ml Ϫ1 ·min Ϫ1 ; r ϭ Ϫ0.51, P Ͻ 0.05). Interestingly, there was no such relationship in older men. That is, there was no correlation between MSNA and FBF responses to ACh and SNP in older men. In addition, MSNA was not related to FVC responses (change and %change) in older men (Figs. 2 and 3) . Fig. 1 . Changes (%) in forearm vascular conductance (FVC) in response to intra-arterial infusion of acetylcholine (ACh; A) and sodium nitroprusside (SNP; B) in older (n ϭ 16) and young (n ϭ 13) men. There was a blunted response in FVC in older men at 4 and 8 g·100 ml Ϫ1 ·min Ϫ1 of ACh vs. young men. This was similar when FVC was expressed as absolute change (see RESULTS) . FVC responses to SNP were similar between young and older men. *P Ͻ 0.05 vs. young men at same dose. 
DISCUSSION
The major new findings of the current study were twofold: 1) there were inverse relationships between MSNA and forearm vasodilator responses to SNP and ACh in young men, and 2) these relationships were not observed in older men. This was inconsistent with our original hypothesis regarding the older group and may seem counterintuitive given what we know about older age, MSNA, and risk of hypertension. However, these findings shed new light on the balance of neurohumoral factors contributing to blood pressure regulation in healthy, older individuals, which help them to remain normotensive despite higher tonic levels of sympathetic (vasoconstrictor) neural activity.
In the young men, lower MSNA was associated with larger vasodilator responses in the forearm to both ACh and SNP. Since the phenomenon occurred for both endothelium-dependent and endothelium-independent responses, it does not appear to be related to the endothelium per se. Rather, our findings suggest that the vasoconstrictor influence of MSNA has the effect of restraining the vasodilator responsiveness of the vascular smooth muscle, perhaps directly via the ␣-adrenergic receptor vasoconstrictor mechanism.
Our present findings in young men are consistent with an earlier report from Engelke and colleagues (8), who used lower body negative pressure (LBNP) to cause a reflex increase in SNA in a group of young healthy subjects. They measured forearm vasodilator responses to ACh and SNP during control conditions and then during Ϫ30 mmHg LBNP. Engelke et al. (8) found that sympathetic activation with LBNP had a restraining influence on the vasodilator responses to both ACh and SNP, suggesting that SNA is able to restrain pharmacological vasodilatation. That previous report provides support for our present interpretation that in young men higher SNA was associated with less forearm vasodilatation due to the vasoconstrictor actions of the SNA itself. However, since neither we nor Engelke et al. (8) performed an intervention to block the SNA-mediated vasoconstriction, we cannot rule out other factors that might have indirectly contributed to the relationships we observed.
The fact that this restraining influence of SNA was not seen in the older men (who showed no relationship between MSNA and forearm vasodilatation) is likely related to the overall higher MSNA in this group. Careful examination of Figs. 2 and 3 (regression figures) shows that the older men had a range of MSNA values that corresponded to the highest end of the range of MSNA values observed in the young men. Therefore, any potential restraining influence of MSNA on vasodilatation in the older men may have been near its maximum even in the individuals with the lowest MSNA for that group. In addition, in the young men, since higher levels of MSNA appear to restrain vasodilatation it is possible that higher levels of MSNA might act to balance high vasodilator capacity. With this in mind, there is a positive relationship between MSNA and circulating plasma nitrates in healthy young men (20) .
Another contributing factor to our observations regarding older men may be the decrease in ␣-adrenergic receptormediated vasoconstriction that has been shown in older compared with young men (6, 21) . Dinenno and colleagues demonstrated that older men have less ␣-adrenergic receptor vasoconstriction in both the forearm and the leg (21) . This may be related to agonist-mediated downregulation of adrenergic receptors in the context of higher SNA and circulating noradrenaline in older people and results in less vasoconstriction for a given amount of SNA in this group (7) .
Our findings of overall lower average vasodilator responses to ACh in the older men are consistent with previous findings of DeSouza and colleagues (5) that older men exhibit less vasodilatation to ACh. Interestingly, the decrease in vasodilator responses to ACh was later shown to be agonist specific: vasodilator responses to substance P, isoproterenol, and bradykinin were not different between older and young healthy men (4) . In terms of our present findings, it is not clear whether the relationships we observed would have been different had we used different pharmacological vasodilators. In addition to this, age-related alterations in vasodilator capacity appear to be limb specific. Newcomer et al. (19) found that there was a reduction in endothelium-dependent vasodilatation (arterial infusions of ACh) in the forearm in older men, but vasodilator capacity appeared to be maintained in the leg. It is possible that our results may be limb specific; this needs to be further investigated.
Our present findings may appear to conflict with an earlier report from our group (3) in which we did not observe a relationship between MSNA and forearm vasodilator responses in a group of young, healthy subjects. However, an important difference between that study and the present study was the inclusion of both men and women in the previous study (1) . Hart and colleagues have demonstrated important differences between young men and women in terms of the vasoconstrictor influences of SNA (11) . Specifically, in young women, ␤-adrenergic receptors cause vasodilatation which offsets ␣-mediated vasoconstriction and results in a net vasoconstriction that is smaller in women than in young men (10) . The differences between the previous findings (3) and the present study may therefore be related to the presence of women in the previous study group.
Clinical perspectives. The risk for developing hypertension increases as people age, as does the activity of sympathetic vasoconstrictor nerves. However, not all older people are hypertensive. Some have successful physiological "strategies" that keep them normotensive despite increases in sympathetic vasoconstrictor neural activity and decreases in endothelium- dependent vasodilation. The present results provide insight into those strategies. We suggest that, in healthy older adults, less ␣-adrenergic vasoconstriction results in a decreased ability of sympathetic nerves to restrain peripheral vasodilator responses. This may lead to more optimal blood flow responses, which then contributes to the integrated balance of neurohumoral mechanisms which maintains normal blood pressure in these older individuals.
Importantly in this context, we only studied normotensive young and older men in these studies. We do not know from the present results how individuals with hypertension (or other cardiovascular disease) would respond in terms of the phenomena we observed in our study groups.
Summary. We measured MSNA and forearm vasodilator responses to local infusions of ACh (endothelium-dependent vasodilator) and SNP (endothelium-independent vasodilator) in healthy young and older men. We found that resting levels of MSNA showed an inverse relationship with vasodilator responses to both agonists in young men, suggesting that SNA may have a restraining influence on vasodilatation in this group. However, this relationship was absent in our group of normotensive older men. The lack of relationship may be related to altered vasoconstrictor responsiveness in older men and/or to the fact that any potential restraining influence was maximized at the lower end of the SNA range in the older group. The present findings provide insight into the integrated balance of factors that contribute to the regulation of blood pressure in healthy older men. 
